Library / Laws / 117th Congress / House Bills / H.R. 7640
H.R. 7640
To amend the Orphan Drug Act to reauthorize a program of grants and contracts for the development of drugs for rare diseases and conditions (commonly referred to as orphan drugs).
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2022-05-03 | 621 B | ⠃⠗⠋ |